St. Jude Medical's Ellipse and SJM Assura line of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators has been approved by the FDA. The next-generation devices come with a low-friction coating to help cut the risk for lead abrasion and feature technology designed to allow high-voltage treatment delivery.

Full Story:
RTT News

Related Summaries